Cargando…

β3 adrenergic receptor antagonist SR59230A exerts beneficial effects on right ventricular performance in monocrotaline-induced pulmonary arterial hypertension

Pulmonary arterial hypertension (PAH) is a progressive disease with a high mortality rate. Previous studies have revealed the important function of the β3 adrenergic receptor (β3-AR) in cardiovascular diseases, and the potential beneficial effects of numerous β3-AR agonists on pulmonary vasodilation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Jiantao, Cheng, Jiali, Ding, Xue, Chi, Jing, Yang, Jiemei, Li, Weimin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6909721/ https://www.ncbi.nlm.nih.gov/pubmed/31853320 http://dx.doi.org/10.3892/etm.2019.8236

Ejemplares similares

β(3)-Adrenoceptor Antagonist SR59230A Attenuates the Imbalance of Systemic and Myocardial Oxygen Transport Induced by Dopamine in Newborn Lambs
por: Gill, Richdeep S., et al.
Publicado: (2012)

Stage-dependent changes of β2-adrenergic receptor signaling in right ventricular remodeling in monocrotaline-induced pulmonary arterial hypertension
por: Sun, Fengjiao, et al.
Publicado: (2018)

Microtubule proliferation in right ventricular myocytes of rats with monocrotaline-induced pulmonary hypertension
por: Stones, Rachel, et al.
Publicado: (2013)

The Beneficial Effect of Suramin on Monocrotaline-Induced Pulmonary Hypertension in Rats
por: Izikki, Mohamed, et al.
Publicado: (2013)

Preventive effect of sildenafil on right ventricular function in rats with monocrotaline-induced pulmonary arterial hypertension
por: Yoshiyuki, Rieko, et al.
Publicado: (2016)

Protective Effect of Right Ventricular Mitochondrial Damage by Cyclosporine A in Monocrotaline-induced Pulmonary Hypertension
por: Lee, Dong Seok, et al.
Publicado: (2018)

Congestive Hepatopathy Secondary to Right Ventricular Hypertrophy Related to Monocrotaline-Induced Pulmonary Arterial Hypertension
por: Gewehr, Douglas Mesadri, et al.
Publicado: (2021)

Thymosin Beta 4 Protects Mice from Monocrotaline-Induced Pulmonary Hypertension and Right Ventricular Hypertrophy
por: Wei, Chuanyu, et al.
Publicado: (2014)

The effect of sildenafil on right ventricular remodeling in a rat model of monocrotaline-induced right ventricular failure
por: Bae, Hyun Kyung, et al.
Publicado: (2016)

Beneficial Effect of Ocimum sanctum (Linn) against Monocrotaline-Induced Pulmonary Hypertension in Rats
por: Meghwani, Himanshu, et al.
Publicado: (2018)

Correction: Thymosin Beta 4 Protects Mice from Monocrotaline-Induced Pulmonary Hypertension and Right Ventricular Hypertrophy
Publicado: (2015)

Rosuvastatin intensifies the beneficial effects of rho-kinase inhibitor in reversal of monocrotaline-induced pulmonary hypertension
por: Jasińska-Stroschein, Magdalena, et al.
Publicado: (2015)

Right ventricular myocardial oxygen tension is reduced in monocrotaline-induced pulmonary hypertension in the rat and restored by myo-inositol trispyrophosphate
por: Oknińska, Marta, et al.
Publicado: (2021)

Up-regulation of hexokinase1 in the right ventricle of monocrotaline induced pulmonary hypertension
por: Zhang, Wei-hua, et al.
Publicado: (2014)

Estrogen and enalapril attenuate the development of right ventricular hypertrophy induced by monocrotaline in ovariectomized rats.
por: Ahn, Byung Hoon, et al.
Publicado: (2003)

Systems approach to the study of stretch and arrhythmias in right ventricular failure induced in rats by monocrotaline
por: Benoist, David, et al.
Publicado: (2014)

Altered mTOR and Beclin-1 mediated autophagic activation during right ventricular remodeling in monocrotaline-induced pulmonary hypertension
por: Deng, Yan, et al.
Publicado: (2017)

Decreased Expression of Canstatin in Rat Model of Monocrotaline-Induced Pulmonary Arterial Hypertension: Protective Effect of Canstatin on Right Ventricular Remodeling
por: Sugiyama, Akira, et al.
Publicado: (2020)

Periostin Mediates Right Ventricular Failure through Induction of Inducible Nitric Oxide Synthase Expression in Right Ventricular Fibroblasts from Monocrotaline-Induced Pulmonary Arterial Hypertensive Rats
por: Imoto, Keisuke, et al.
Publicado: (2018)

Exercise preconditioning prevents left ventricular dysfunction and remodeling in monocrotaline-induced pulmonary hypertension
por: Schmidt, Cristine, et al.
Publicado: (2020)

Inhalation of the BK(Ca)-Opener NS1619 Attenuates Right Ventricular Pressure and Improves Oxygenation in the Rat Monocrotaline Model of Pulmonary Hypertension
por: Revermann, Marc, et al.
Publicado: (2014)

Expression profile of matricellular proteins in hypertrophied right ventricle of monocrotaline-induced pulmonary hypertensive rats
por: IMOTO, Keisuke, et al.
Publicado: (2017)

Role of oxidative stress versus lipids in monocrotaline‐induced pulmonary hypertension and right heart failure
por: Farahmand, Firoozeh, et al.
Publicado: (2021)

Role of Endothelin-1 in Right Atrial Arrhythmogenesis in Rabbits with Monocrotaline-Induced Pulmonary Arterial Hypertension
por: Lu, Yen-Yu, et al.
Publicado: (2022)

Effects of Single Drug and Combined Short-term Administration of Sildenafil, Pimobendan, and Nicorandil on Right Ventricular Function in Rats With Monocrotaline-induced Pulmonary Hypertension
por: Nakata, Telma M., et al.
Publicado: (2015)

Protective effects of Dapagliflozin on the vulnerability of ventricular arrhythmia in rats with pulmonary artery hypertension induced by monocrotaline
por: Qin, Tianyou, et al.
Publicado: (2022)

Pipersentan: A De Novo Synthetic Endothelin Receptor Antagonist that Inhibits Monocrotaline- and Hypoxia-Induced Pulmonary Hypertension
por: Zhang, Zeyu, et al.
Publicado: (2022)

Right Ventricle Remodeling Metabolic Signature in Experimental Pulmonary Hypertension Models of Chronic Hypoxia and Monocrotaline Exposure
por: Hautbergue, Thaïs, et al.
Publicado: (2021)

An inhibitory effect of tumor necrosis factor-alpha antagonist to gene expression in monocrotaline-induced pulmonary hypertensive rats model
por: Kwon, Jung Hyun, et al.
Publicado: (2013)

Lodenafil treatment in the monocrotaline model of pulmonary hypertension in rats
por: Polonio, Igor Bastos, et al.
Publicado: (2014)

Arginase Inhibition Reverses Monocrotaline-Induced Pulmonary Hypertension
por: Jung, Christian, et al.
Publicado: (2017)

Cannabidiol Ameliorates Monocrotaline-Induced Pulmonary Hypertension in Rats
por: Sadowska, Olga, et al.
Publicado: (2020)

An integrated proteomic and transcriptomic signature of the failing right ventricle in monocrotaline induced pulmonary arterial hypertension in male rats
por: Hindmarch, Charles Colin Thomas, et al.
Publicado: (2022)

Therapeutic Approaches in Pulmonary Arterial Hypertension with Beneficial Effects on Right Ventricular Function—Preclinical Studies
por: Balsa, André, et al.
Publicado: (2023)

Involvement of mast cells in monocrotaline-induced pulmonary hypertension in rats
por: Dahal, Bhola K, et al.
Publicado: (2011)

Simvastatin, Sildenafil and Their Combination in Monocrotaline Induced Pulmonary Arterial Hypertension
por: Lee, Dong Seok, et al.
Publicado: (2010)

Therapeutic efficacy of TBC3711 in monocrotaline-induced pulmonary hypertension
por: Kosanovic, Djuro, et al.
Publicado: (2011)

Quercetin attenuates the progression of monocrotaline-induced pulmonary hypertension in rats
por: Gao, Hanhua, et al.
Publicado: (2012)

Maprotiline Prevents Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats
por: Tong, Yi, et al.
Publicado: (2018)

Magnesium Sulfate Mitigates the Progression of Monocrotaline Pulmonary Hypertension in Rats
por: Chang, Chao-Yuan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_guq09ge1r7n3n6vbt1emfusb4t